Skip to main content
. 2018 Feb 14;2(4):403–413. doi: 10.1007/s41669-018-0068-1

Table 2.

Estimated incremental cost-effectiveness ratios in the different costing scenarios

Resource categories included
CHD CVD All
ICER £28,626 per QALY £28,395 per QALY £29,485 per QALY

CHD coronary heart disease, CVD cardiovascular disease, ICER incremental cost-effectiveness ratio, QALY quality-adjusted life-year